Champions Oncology (CSBR) Exchange Rate Effect (2010 - 2014)
Champions Oncology (CSBR) posted quarterly Exchange Rate Effect of $18000.0 for Q4 2014, up 325.0% year-over-year from $4235.3 in Q4 2013, and up 200.0% quarter-over-quarter from -$18000.0 in Q3 2014.
Champions Oncology (CSBR) Exchange Rate Effect (2010 - 2014) Analysis & Trends
Champions Oncology's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at $18000.0 for Q4 2014.
- In Q4 2014, Exchange Rate Effect rose 325.0% year-over-year to $18000.0; the TTM figure through Jul 2015 stood at $18000.0 (up 160.0% YoY), while the FY2014 annual figure was -$24000.0, down 196.0% from the prior year.
- Exchange Rate Effect for Q4 2014 stood at $18000.0, up from -$18000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $25000.0 in Q3 2012, with the low at -$56000.0 in Q2 2012.
- The 5-year median for Exchange Rate Effect is -$2000.0 (2013), against an average of -$6647.1.
- The sharpest annual moves came in 2013 and 2014: Exchange Rate Effect sank 500.0% in 2013, then jumped 325.0% in 2014.
- Champions Oncology's Exchange Rate Effect stood at -$28000.0 in 2010, then soared by 125.0% to $7000.0 in 2011, then sank by 71.43% to $2000.0 in 2012, then tumbled by 500.0% to -$8000.0 in 2013, then surged by 325.0% to $18000.0 in 2014.
- Business Quant data shows CSBR's Exchange Rate Effect at $18000.0 in Q4 2014, -$18000.0 in Q3 2014, and $3000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2014 | 18,000.00 |
| Oct 31, 2014 | 18,000.00 |
| Jul 31, 2014 | -18,000.00 |
| Jul 31, 2014 | -18,000.00 |
| Apr 30, 2014 | 3,000.00 |
| Apr 30, 2014 | 3,000.00 |
| Jan 31, 2014 | -7,000.00 |
| Jan 31, 2014 | -7,000.00 |
| Oct 31, 2013 | -8,000.00 |
| Oct 31, 2013 | -8,000.00 |
| Jul 31, 2013 | -12,000.00 |
| Jul 31, 2013 | -12,000.00 |
| Jan 31, 2013 | -2,000.00 |
| Jan 31, 2013 | -2,000.00 |
| Oct 31, 2012 | 2,000.00 |
| Oct 31, 2012 | 2,000.00 |
| Jul 31, 2012 | 25,000.00 |
| Jul 31, 2012 | 25,000.00 |
| Apr 30, 2012 | -56,000.00 |
| Apr 30, 2012 | -56,000.00 |